The AlphaLISA™ SureFire® Ultra™ Human Total MYD88 assay is a sandwich immunoassay for quantitative detection of total MYD88 in cellular lysates using Alpha technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human Total MYD88 assay is a sandwich immunoassay for quantitative detection of total MYD88 in cellular lysates using Alpha technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Toll-like or interleukin-1 receptors (TLR/IL-1R) signaling is mediated by Myeloid Differentiation Factor 88 (MYD88), a crucial adapter that mediates the onset of the innate immune response and the generation of proinflammatory cytokines that inhibit pathogens and activate adaptive immunity. While a host's ability to fend off pathogenic infection depends on MYD88, disruption of its abundance can result in autoimmune disorders. One important mechanism for stopping the production of cytokines is the degradation of MYD88.
The AlphaLISA SureFire Ultra Human Total MYD88 Detection Kit is a sandwich immunoassay for the quantitative detection of total MYD88 in cellular lysates, using Alpha technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
Alpha SureFire kits can be used for:
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Host Species |
Human
|
Lysis Buffer Compatibility |
Lysis Buffer
|
Molecular Modification |
Total
|
Product Group |
Kit
|
Sample Volume |
10 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
MYD88
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
Alpha
|
Therapeutic Area |
Autoimmunity
|
Unit Size |
500 Assay Points
|
THP-1 cells were seeded in a 96-well culture plate (80,000 cells/well) in complete medium, treated with 100 nM PMA and incubated for 24 hours at 37°C, 5% CO2. The cells were further treated with increasing concentrations of LPS for 24 hours. After treatment, the cells were washed in HBSS and lysed with 100 µL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. Lysates were further diluted 1:5 in lysis buffer before proceeding to the detection step. MYD88 Total and NFkB Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 1,600 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus™ using standard AlphaLISA settings.
Karpas299 cells were harvested, washed in HBSS + 0.1% BSA and seeded in a 96-well culture plate (100,000 cells/well) in HBSS + 0.1% BSA. The cells were further treated with increasing concentrations of IL-1b for 10 minutes.
After treatment, the cells were lysed with 50 µL of 5X lysis buffer for 10 minutes at RT with shaking at 350 rpm. MYD88 Total, IRAK4 Phospho (Thr345/Ser346) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings.
Total MYD88 protein levels were assessed in A549 wild type (WT) cells and MYD88 knockout (KO) A549 cells. Both cell lines were grown to confluency in a T175 flask in complete medium. Each flask was lysed in 4 mL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. Lysates were serially diluted in lysis buffer and evaluated for MYD88 Total as well as Cofilin Total levels to ensure normalization (data not shown). For the detection step, 10 µL of cell lysate were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings. As expected, MYD88 was detected in the WT-A549 cells but not in the MYD88-KO cell line.
HeLa cells were seeded at different densities in a 96-well plate (200 µL/well) in complete culture medium and incubated overnight at 37°C, 5% CO2. Cells were siRNA treated with 50 µL of a mix of transfection reagent (Santa Cruz, sc-29528)/MYD88 siRNA (Santa Cruz, sc- 35986) or a mix of transfection reagent/siRNA control (Santa Cruz, sc-37007) for 48 hours. After treatment, the cells were lysed with 100 µL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. MYD88 Total levels were evaluated by AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus using standard AlphaLISA settings.
Are you looking for resources, click on the resource type to explore further.
Lysine 27 Dimethylation Detection with AlphaLISA Technology
In this technical note discover how AlphaLISA immunodetection assay...
Quantification of Histone H3 Lysine 9 Di-Methylation Using AlphaLISA Assay
In this technical note discover how The AlphaLISA assay...
Discover the next generation of immunoassay kits with Revvity's newly released AlphaLISA and HTRF assay targets. Our R&D...
We are here to answer your questions.